About
OneOme

OneOme's mission

OneOme is working to deliver the highest quality, most cost-effective pharmacogenomic testing and tools for all providers across the globe to use in everyday patient care. By increasing adoption of pharmacogenomics, OneOme and the RightMed test may help providers make more informed medication decisions, with the aim of decreasing medication trial and error and reducing healthcare costs.

Investment opportunities

If you are interested in being a part of the future of precision medicine and would like to discuss investment opportunities with OneOme, please contact us at investorrelations@oneome.com.

People of OneOme

Leadership Toggle icon

  • Patrick McIntyre

    PATRICK MCINTYRE — CHIEF EXECUTIVE OFFICER

    Patrick joined OneOme as Chief Executive Officer in July 2019. Patrick has more than 25 years of healthcare experience, the vast majority of which has been in leadership roles over advanced analytics, healthcare economics, clinical informatics, and medical finance in national and regional payer organizations. He has built and led industry-leading analytics capabilities at UnitedHealthcare/Optum, Anthem, and Aetna. Patrick received his MBA from Winthrop University and his BBA from Texas Tech University. He is a former Certified Public Accountant in South Carolina, and he served for 5 years on active duty in the United States Marine Corps.

  • Jason Ross

    Jason Ross — CHIEF TECHNOLOGY OFFICER

    Jason is the Chief Technology Officer with over 20 years of Healthcare Information Technology experience. Prior to joining OneOme, Jason held the position of IT Section Head at Mayo Clinic and was responsible for leading their IT strategy for genomics, informatics and advanced analytics. In addition, he was the Associate Director of IT for Mayo Clinic’s Center for Individualized Medicine. Jason holds a B.S. in molecular biology from University of Wisconsin – Eau Claire and a M.A. in Healthcare Administration from St. Mary’s University of Minnesota.

  • Brian Arendt

    BRIAN ARENDT — SENIOR DIRECTOR OF COMMERCIAL OPERATIONS

    Brian joined OneOme as the Director of Commercial Operations in October 2015. Previously, he held management roles in operations, analytics, and IT for a genetic information company, diagnostic reference laboratory, and an integrated health system. Brian has a B.S. in marketing from Winona State University and an M.B.A. from the University of Wisconsin — La Crosse.

  • Clayton Weiby

    Clayton Weiby — Senior Director of Finance

    Clayton leads the finance and accounting function for OneOme. He is an experienced business leader with 20+ years of experience in finance, accounting, business development, training, and trading. Clayton received his MBA in Finance from the University of Minnesota's Carlson School of Business and his undergraduate degree in Accounting and Spanish from the University of St. Thomas.

  • Jason Sheard

    JASON SHEARD — SENIOR DIRECTOR OF PRODUCT DEVELOPMENT

    Jason is the Director of Product Development at OneOme. He is a technical leader with diverse product development experience, outstanding customer and engineering management skills, and a proven ability to build consensus and motivate teams to excel. Previously, he was the Vice President of Products for Logic PD, and before that he was Director of Electrical Engineering. Jason has a B.S. in physics from Bethel University and an M.S. in mechanical engineering from the University of Minnesota — Twin Cities.

  • Kesah Scmitt

    KESAH SCHMITT — SENIOR DIRECTOR OF MARKETING

    Kesah joined OneOme in 2016 and is the Director of Marketing. She has over ten years experience helping companies launch and grow their businesses. With a background in marketing, product development, and healthcare innovation, Kesah has worked with organizations like Mayo Clinic and Boston Scientific to develop and execute marketing strategies. Kesah received her B.A from Tulane University.

  • Mark Billmayer

    MARK BILLMAYER — SENIOR DIRECTOR OF PGX PROGRAM DEVELOPMENT

    Mark leads pharmacogenomics program development for OneOme, focusing on plan sponsors and PBMs. He has worked in many facets of healthcare including health plans, hospitals and clinics, PBMs, pharmacies, consulting and marketing firms, and technology startups. Most recently, Mark served as Director of Product Development within Specialty Pharmacy for OptumRx. Previously, with Intellogy Health Designs, he consulted on a wide variety of projects with US Oncology, Teradata, Fujitsu, McKesson/Relay Health, Rocky Mountain Cancer Centers and more. Mark received his B.S. in health and medical marketing from the University Wisconsin-Superior.

  • Stephen Floe

    STEPHEN FLOE — SENIOR DIRECTOR OF STRATEGIC PARTNERSHIPS

    Stephen leads strategic partner initiatives at OneOme. Prior to OneOme, he led corporate strategy for a novel in-vitro diagnostic company, including its financing and triple aim focus. His healthcare finance background includes Bank of America Merrill Lynch, where he supported leading medical companies, evaluating and advancing opportunities for new technologies. His experience includes facilitating collaboration in healthcare across continents; he has traveled extensively in Asia. Steve received his B.A. in Business & Economics from Wheaton College in Illinois. He is passionate about value-based healthcare.

Board Members

  • Danny Cunagin

    DANNY CUNAGIN — CHAIRMAN OF THE BOARD

    Danny Cunagin is Co-CEO of Invenshure, a venture catalyst that identifies, incubates, funds and grows emerging technology companies ready for commercialization. He is acting CEO of Invenshure’s portfolio companies in medical imaging and biotechnology and previously was the Chief Executive Officer and Chairman of the Board of Steady State Imaging and was CEO, Chairman, and majority owner of Logic Product Development. He was noted as one of “forty under 40” in 1999 by City Business, and has a B.S.M.E. from the University of Kentucky.

  • Troy Kopischke

    TROY KOPISCHKE — CO-FOUNDER

    Troy is the co-founder and chairman of the board of OneOme. He is also a co-CEO, co-founder, and managing partner of Invenshure. Previously, he was the President and Chief Financial Officer at Steady State Imaging, where he was instrumental in developing a commercialization strategy that helped guide the sale of the company to GE Healthcare in 2011. Troy holds a B.S. in electrical engineering from the University of Minnesota as well as a B.A. in physics and a B.A. in engineering science from Bethel College.

  • Patrick McIntyre

    PATRICK MCINTYRE — CHIEF EXECUTIVE OFFICER

    Patrick joined OneOme as Chief Executive Officer in July 2019. Patrick has more than 25 years of healthcare experience, the vast majority of which has been in leadership roles over advanced analytics, healthcare economics, clinical informatics, and medical finance in national and regional payer organizations. He has built and led industry-leading analytics capabilities at UnitedHealthcare/Optum, Anthem, and Aetna. Patrick received his MBA from Winthrop University and his BBA from Texas Tech University. He is a former Certified Public Accountant in South Carolina, and he served for 5 years on active duty in the United States Marine Corps.

  • Jeremy Friese

    Jeremy Friese, M.D., MBA

    Jeremy is a “recovering Mayo physician” turned entrepreneur and director. He is founder and CEO at Verata Health, an Insurtech company using artificial intelligence to create frictionless prior authorization between healthcare providers and payers. He is also founder and director of Ostra, a cybersecurity company focused on small and medium businesses. Previously, Jeremy was an interventional radiologist at Mayo Clinic with numerous departmental and institutional leadership responsibilities. Jeremy earned his MD at Mayo Clinic and completed surgery and radiology training at Mayo Clinic and Harvard Medical School. He earned his MBA at Harvard Business School.

  • Mark Sylvester

    MARK SYLVESTER

    Mark Sylvester is President and former CFO of Invenshure. He is also acting CFO of Invenshure's portfolio companies. He previously served as the CFO of The Emily Project from 2012-2015. Mark holds a J.D. from the University of St. Thomas School of Law, and a B.A. in Political Science and Accounting from Saint John’s University. Mr. Sylvester was named 2018 CFO of the Year by the Minneapolis/St. Paul Business Journal.

  • Tom Vanderheyden

    Tom Vanderheyden

    Tom served most recently as EVP and President, Diversified Business at Blue Cross and Blue Shield of Minnesota. Prior to joining Blue Cross and Blue Shield of Minnesota in 2017, he held multiple leadership roles over the course of 13 years at UnitedHealth Group (UHG). In 2015, he co-founded and served as chief executive officer at Harken Health Insurance Company, an independently operated affiliate of UHG. His tenure at UHG also included leadership positions in business development and innovation; UnitedHealth International; global operations; strategic sourcing; and mergers and acquisitions. Additionally, his career includes two decades of experience that encompasses systems engineering and sales at IBM, creating a national IT outsourcing business and managing a regional consulting firm. Tom holds a Master of Business Administration in global management from the University of Phoenix and a bachelor’s degree in organizational management and communications from Concordia University.

Advisors

  • John Black

    JOHN L. BLACK III, M.D. — MAYO CLINIC, CO-FOUNDER ONEOME

    John L. Black III, M.D. is one of the co-founders of OneOme and also a consultant in the Division of Clinical Biochemistry and Immunology with a joint appointment in the Department of Psychiatry and Psychology at Mayo Clinic in Rochester. He joined the staff of Mayo Clinic in 1985 and is currently the co-director of the Personalized Genomics Laboratory. He received his B.A. and M.S. in psychology from the University of Wyoming. He received his M.D. (cum laude) from Creighton University School of Medicine. He is board certified in general, geriatric, and addiction psychiatry and is a clinical chemist.

  • Liewei Wang

    LIEWEI WANG, M.D., Ph.D. — MAYO CLINIC, Co-founder OneOme

    Dr. Wang is a professor in the Department of Molecular Pharmacology and Experimental Therapeutics (MPET) at Mayo Clinic Rochester. Her research involves the application of high-throughput "omics" technologies to identify biomarkers that might help us individualize cancer therapies, understand mechanisms of drug action, and facilitate target identification and drug development. She is also a co-leader of the Mayo Pharmacogenomics Program within the Mayo CIM, where many of the projects involving personalized medicine have been conducted. She is the co-PI for the Mayo-NIH clinical pharmacology T32 training grant and the Associate Director for the Mayo MPET graduate program.

  • Richard Weinshilboum

    RICHARD WEINSHILBOUM, M.D. — MAYO CLINIC, Co-founder OneOme

    Dr. Weinshilboum received B.A. and M.D. degrees from the University of Kansas, followed by residency training in internal medicine at the Massachusetts General Hospital. He was also a pharmacology Research Associate at the National Institutes of Health (NIH). He began his affiliation with the Mayo Medical School and Mayo Clinic in 1972, where he is presently Professor of Pharmacology and Medicine and Mary Lou and John H. Dasburg Professor of Cancer Genomics Research. He currently directs the Pharmacogenomics Program of the Mayo Center for Individualized Medicine and is co-Principal Investigator of the long-standing US NIH Pharmacogenomics Research Network Center at the Mayo Clinic.

  • Carmen Kosicek, MSN, PMHNP - Advisory Board Member

    Carmen Kosicek, MSN, PMHNP - Advisory Board Member

    Carmen Kosicek, RN, MSN is the CEO & founder of Alay Health Team, a psychiatric clinic caring for children and adults both on-site and via telemedicine. She is also the clinical medical director at Dodge County Bridges, a nonprofit committed to providing supervised residential and support services to adult clients transitioning from rehabilitation to recovery from substance abuse. Carmen’s healthcare career has spanned clinical positions in nuclear medicine, labor and delivery BSN-RN in women’s health, OB nurse manager, and as an advanced practice nurse-midwife. She has 10+ years of experience teaching across an array of LPN, ADN, and BSN levels. Carmen received an Associate of Applied Science in Nuclear Medicine from Triton College, a Bachelor of Science in Nursing from the University of St. Francis, a Master of Science in Nursing from Case Western Reserve University, and a postgraduate certificate as an advanced practice nurse in nurse-midwifery at Frontier University.

  • Dragan Primorac, MD, PhD - Advisory Board Member

    DRAGAN PRIMORAC, M.D., PH.D. — ADVISORY BOARD MEMBER

    Prof. Dragan Primorac is a pediatrician, forensic expert and geneticist. He is the first recipient of the title “Global Penn State University Ambassador”. Currently he serves as President of International Society for Applied Biological Sciences, Chair of the International Affairs Committee of the American Academy of Forensic Sciences, President of the State Competitiveness Cluster in Personalized Medicine, President of The Croatian Society for Human Genetics, Director of World Academy of Pain Medicine Ultrasonography (Central European Chapter), and as a member of the International Consortium for Personalized Medicine Executive Committee (IC PerMEd) established by The European Commission. Dr. Primorac is a professor at Eberly College of Science, Pennsylvania State University; Henry C. Lee College of Criminal Justice and Forensic Sciences, University of New Haven; Medical Schools in Split, Osijek, and Rijeka, Croatia; and the Department of Biotechnology, University of Rijeka, in Croatia. From 2003 to 2009 he served as Minister of Science, Education and Sports of The Republic of Croatia.

  • Paldeep S. Atwal, M.B., Ch.B. - Advisory Board Member

    Paldeep S. Atwal, M.B., Ch.B. - Advisory Board Member

    Dr. Atwal is a board-certified clinical and medical biochemical geneticist who formerly served at Mayo Clinic’s Jacksonville campus as medical director for the Center for Individualized Medicine and clinical lead for the Department of Clinical Genomics. He is a fellow of both The American College of Medical Genetics & Genomics and The Royal Colleges of Physicians of the United Kingdom. He received his medical degree from the University of Glasgow, Scotland and initially trained in hospital internal medicine with The Royal College of Physicians at Glasgow Royal Infirmary and various other hospitals around the Glasgow area. He completed his medical genetics residency at Stanford University Medical Center in Palo Alto, CA and his sub-specialty medical biochemical genetics fellowship at Baylor College of Medicine in Houston, TX. Additionally, he holds diplomas in Structural Molecular Biology and Forensic Medical Science.

  • Ross Higgins

    ROSS HIGGINS — ADVISOR

    Ross joined OneOme in early 2016 to establish the company’s laboratory team and operational capabilities, successfully overseeing its CLIA certification, NY accreditation, and multiple CAP inspections. He now serves as an advisor to the company on matters of laboratory and scientific strategy. Before his involvement in OneOme, Ross led cross-functional product development and business development efforts at Douglas Scientific, a global leader of high-throughput genomic instrumentation in agricultural and clinical testing applications. In addition, Ross has previously held management and technical roles in other early stage and rapid-growth diagnostics/laboratory startup ventures. Ross has a B.S. in Clinical Laboratory Science and an M.B.A. from Virginia Commonwealth University. He also maintains ASCP certification as a Medical Laboratory Scientist.

  • Scott A. Storrer, MBA - Advisory Board Member

    Scott A. Storrer, MBA - Advisory Board Member

    Scott is responsible for the strategic development and expansion of the eHealth product line. A 25-year healthcare industry veteran, Scott brings deep, diverse and innovative experience in leading and growing healthcare businesses, having held senior management positions at Strand Life Sciences, a personalized medicine and biotechnology software solution provider and FirstLab, a third party administrator for substance abuse monitoring. Earlier in his career, Scott served as group president of Cardinal Health’s $81B pharmaceutical segment and executive vice president of Service and Technology for CIGNA.

  • Steven Tucker, MD, FACP, FAMS - Advisory Board Member

    Steven Tucker, MD, FACP, FAMS - Advisory Board Member

    While originally trained as a cancer specialist at the UCLA Center for Health Sciences, Dr. Tucker currently focuses on both adult general medicine and cancer medicine. Dr. Tucker is also an expert in medical technology and digital health. By studying information from multiple sources, such as personal genetics, metabolic testing, sensors and activity trackers, he helps patients develop personalized health plans that combine the elements of behavioral change with those of conventional medicine, as necessary. Dr. Tucker has received numerous honors and awards including a prestigious Merit Award from the American Society of Clinical Oncology and a Commendation from the U.S. National Institutes of Health. Dr. Tucker is a fellow of the American College of Physicians (FACP) and the Academy of Medicine, Singapore (FAMS), as well as an officer of the Chapter of Medical Oncologists, College of Physicians Singapore (CPS).

Team Toggle icon

Alice Kirchhoff

Marketing

Alice
Kirchhoff

Ben Metzger

Software Development

Ben
Metzger

Bernard Esquivel, MD, MHA, PhD

Medical Affairs

Bernard
Esquivel, MD, MHA, PhD

Brett Miller

Business Development

Brett
Miller

Bronwyn Hartung, PhD, HCLD(ABB)

Laboratory Operations

Bronwyn
Hartung, PhD, HCLD(ABB)

Catie Pfeilsticker

Laboratory Operations

Catie
Pfeilsticker

Chiara Aziz

Laboratory Operations

Chiara
Aziz

Colin Pistulka

Commercial Operations

Colin
Pistulka

Colleen Owen

Human Resources

Colleen
Owen

Erica Schnettler, PhD

Medical Affairs

Erica
Schnettler, PhD

Erik Anderson

IT

Erik
Anderson

Hunter Kievet

Software Development

Hunter
Kievet

Jacob Sevlie

Software Development

Jacob
Sevlie

Jordan Gutzman

Sales

Jordan
Gutzman

Julie Ceno-England, MD

Medical Affairs

Julie
Ceno-England, MD

Julie Hessick, RPh

Business Development

Julie
Hessick, RPh

Karl Ruch, PharmD, BCPS

Medical Affairs

Karl
Ruch, PharmD, BCPS

Kathleen Bosse, PharmD

Clinical Development

Kathleen
Bosse, PharmD

Kirsten Bauer

Laboratory Operations

Kirsten
Bauer

Kurt Wiersma

Software Development

Kurt
Wiersma

Lilly Drew

Commercial Operations

Lilly
Drew

Lori Borchers

Business Development

Lori
Borchers

Lydia Kantor

Marketing

Lydia
Kantor

Matt Hilden

Software Development

Matt
Hilden

Megan Adelman, PharmD

Clinical Development

Megan
Adelman, PharmD

Morgan Donaldson

Business Development

Morgan
Donaldson

Rissa Hall

Commercial Operations

Rissa
Hall

Steve Sheldon

IT

Steve
Sheldon

Tyler Koep, PhD

Medical Affairs

Tyler
Koep, PhD

Vaishnavi Soundararajan, PharmD (Intl.), MS

Clinical Development

Vaishnavi
Soundararajan, PharmD (Intl.), MS

Vince Catania

Business Development

Vince
Catania

Wrenda Teeple, PharmD

Clinical Development

Wrenda
Teeple, PharmD

Select partners

tucker logo
medcan logo
doseme logo
personamed logo
rainbow logo
chemowave logo
Precision Med logo
St. Catherine logo
Apollo Clinical Pharmacy Logo

Awards

fast company logo

Named one of the World's 50 Most Innovative Companies for 2018 by Fast Company.

#22 overall | #2 in biotech

Icon
Icon
Icon

  • The RightMed test must be ordered by a physician.
  • The RightMed test, as with all genomic testing, has limitations. Always discuss the test with a healthcare provider knowledgeable about the test and to see if it's right for you.
  • RightMed test results are not a substitute for medical advice and should only be used in consultation with a medical professional.
  • The RightMed test does not determine the best medication for the patient; it is a tool to provide additional information to the patient’s healthcare provider. The healthcare provider should take other factors into consideration regardless of genotype.
  • Independent healthcare providers available through OneOme's service will not have all of your health history, which may cause the test results to be subject to a different interpretation than by your personal physician.
  • DO NOT MAKE ANY CHANGES TO YOUR CURRENT MEDICATIONS OR DOSING WITHOUT CONSULTING YOUR HEALTHCARE PROVIDER.